Use of Fluorescence and Reflectance Imaging for diagnosis of abnormalities within the gastrointestinal tract

Diagnostic utility of Fluorescence and Diffuse Reflectance Imaging in gastrointestinal luminal pathology

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030415

Enrollment

Registered

2021-01-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C15-C26- Malignant neoplasms of digestive organs

Interventions

Intervention1: Acquiring images of the excised specimens of the gastrointestinal lesion with an indigenous device which utilizes fluorescence and diffuse reflectance.: The excised specimens obtained d

Eligibility

Inclusion criteria

Inclusion criteria: All patients above 18 years of age operated by the General Surgery Department of Kasturba Hospital, Manipal for gastrointestinal luminal malignancies during the study period

Exclusion criteria

Exclusion criteria: Age less than 18 years

Design outcomes

Primary

Measure	Time frame
Determine the utility of Fluorescence and diffuse reflectance imaging in the diagnosis of Gastrointestinal lesions.Timepoint: 15 days (to obtain the report of HPE and validate the diagnosis)	—

Secondary

Measure	Time frame
1. Feasibility of identification of tumour free margins intraoperatively using Fluorescence and Diffuse reflectance. 2. Identification of premalignant lesions. 3. Differentiating malignant from benign lesionsTimepoint: 15 days (to obtain the report of HPE and validate the diagnosis)	—

Countries

India

Contacts

Public ContactDr Sharun Abey Kurian

Department of General Surgery, Kasturba Medical College, Manipal.

stanley.mathew@manipal.edu9844409900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026